Technology
High Throughput Screening (HTS) Market to Grow by USD 19.9 Billion (2024-2028), Boosted by Rising R&D Investments, with AI Redefining Market Landscape – Technavio
Published
1 year agoon
By
NEW YORK, Jan. 31, 2025 /PRNewswire/ — Report with market evolution powered by AI – The global high throughput screening (HTS) market size is estimated to grow by USD 19.9 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 12.12% during the forecast period. Rise in R and D investments is driving market growth, with a trend towards increasing focus on promotional activities. However, shortage of trained healthcare professionals poses a challenge. Key market players include Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..
Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF
High Throughput Screening (HTS) Market Scope
Report Coverage
Details
Base year
2023
Historic period
2018 – 2022
Forecast period
2024-2028
Growth momentum & CAGR
Accelerate at a CAGR of 12.12%
Market growth 2024-2028
USD 19.9 billion
Market structure
Fragmented
YoY growth 2022-2023 (%)
11.64
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 40%
Key countries
US, Japan, China, Germany, and France
Key companies profiled
Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc.
Market Driver
High-throughput screening (HTS) is a key trend in the life sciences sector, particularly in the areas of drug discovery and research for complex illnesses like cancer and neurological disorders. HTS allows for the rapid testing of large compound libraries using automated equipment such as robotic arms and microplate readers. Data analytics plays a crucial role in HTS, with machine learning and data management systems used to analyze genomic data and chemical databases for target identification. Biotech startups and academic institutions are driving innovation in this field, with pharmaceutical corporations and research organizations collaborating to advance drug development. HTS is also used in stem cell research, toxicology, and open innovation models. HTS service providers offer instruments, software, and consumables to support this research. HTS is transforming the biopharmaceutical industry, enabling precision medicine and the repurposing of existing drugs for new indications. With advancements in technology, HTS is becoming more accessible to a wider range of organizations, including biotechnology startups and clinical trials. Despite these advancements, challenges remain, including false-positive findings and the need for specialized equipment maintenance. Overall, HTS is a vital tool in the global healthcare sector’s quest to develop new products and services for the detection and treatment of chronic diseases.
The High Throughput Screening (HTS) market presents unique challenges for vendors due to its specialized nature and niche end-users. Brand and product visibility play a limited role in sales, and advertising and marketing are restricted. Key players in the industry recognize this issue and are promoting HTS through their websites and additional support materials. Thermo Fisher Scientific, for instance, provides explanatory documents, brochures, and interactive videos on YouTube to help end-users understand the technique better. Despite these efforts, there is a significant lack of awareness about HTS. Vendors must focus on improving their distribution networks to make these products readily available to end-users.
Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!
Market Challenges
High-throughput screening (HTS) is a crucial process in the biotechnology industry, enabling the rapid identification of potential drug candidates for complex illnesses such as cancer and neurological disorders. The market for HTS is vast and diverse, with players including academic institutions, biotech startups, and pharmaceutical corporations. Challenges in this field include managing large data sets from compound libraries, dealing with false-positive findings, and maintaining specialized equipment. HTS involves the use of automation, robotics, and specialized instruments like microplate readers and high-resolution imaging systems. Data analytics is essential for making sense of the vast amounts of data generated. Machine learning and data management systems help in data organization, retrieval, integration, and storage. HTS is not just limited to pharmaceutical companies but also extends to the global healthcare sector, research organizations, and contract research organizations. Collaborative networks and HTS service providers play a significant role in driving innovation through open innovation models. HTS is also used in stem cell research, toxicology, and drug development. HTS involves various techniques like cell-based assays, lab-on-a-chip, and label-free technology. Biochemical screening and target identification are critical components of the HTS process. Drug repurposing initiatives, such as those from Relay Therapeutics, are gaining popularity in the biopharmaceutical industry due to their potential to bring new drugs to market faster and more cost-effectively. The HTS market is expected to grow significantly due to the increasing focus on precision medicine and the need for new drugs to address chronic diseases. Consumables, software, and services are essential products and services in the HTS market. The use of technology in HTS, such as automation and advanced detection techniques, is transforming the drug discovery process. Despite the challenges, the future of HTS looks promising, with advancements in technology and a growing focus on collaboration and open innovation models. The use of HTS in drug discovery and development is expected to revolutionize the way we approach complex illnesses and bring new treatments to market.In today’s fast-paced pharmaceutical and biotechnology industries, High Throughput Screening (HTS) has become a crucial tool for discovering new drugs and optimizing existing ones. However, the successful implementation of HTS relies heavily on the availability of skilled personnel. The shortage of trained professionals in this field can lead to non-compliance and improper screening of drug targets. Consequently, product failures and regulatory issues can result in significant financial losses for companies. This issue is particularly prevalent in developing countries, where the healthcare system lacks the necessary workforce to effectively utilize HTS technology. To mitigate this challenge, it is essential for organizations to invest in training and development programs for their staff, ensuring they have the necessary expertise to operate HTS equipment effectively and efficiently.
Discover how AI is revolutionizing market trends- Get your access now!
Segment Overview
This high throughput screening (HTS) market report extensively covers market segmentation by
Application 1.1 Target identification and validation1.2 Primary and secondary screening1.3 Toxicology assessment1.4 Stem cell researchEnd-user 2.1 Pharmaceutical and biotechnology companies2.2 Academic and research institutes2.3 CROsGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)
1.1 Target identification and validation- The global high throughput screening (HTS) market is driven by the increasing need for target identification and validation in drug development. This process involves finding potential therapeutic targets for diseases or conditions without existing treatments or inadequate current options. Early and thorough target identification and validation establish a strong link to clinical trial success. Chronic diseases like cardiovascular diseases, cancer, and respiratory diseases, which have a high global prevalence, fuel the demand for new targets. Additionally, the growing pipeline for biological candidates, outsourcing from pharmaceutical companies, and regulatory agencies’ demand for accurate drug and process development details contribute to market expansion. Advanced bioinformatics tools, automated experimental designs, and AI/ML algorithms are enhancing target identification and validation, further boosting the segment’s growth. Consequently, these factors are expected to fuel the growth of the target identification and validation segment in the global high throughput screening market during the forecast period.
Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics
Research Analysis
High-throughput screening (HTS) is a critical technology in the global healthcare sector, enabling the rapid and efficient identification of potential drug candidates for complex illnesses such as cancer and neurological disorders. HTS utilizes compound libraries, often containing hundreds of thousands to millions of compounds, which are screened against disease targets using automated systems. These systems include robotic arms, microplate readers, and high-resolution imaging systems. Data analytics plays a crucial role in HTS, with data management systems, data storage, data organization, data retrieval, data integration, and chemical databases essential for processing and interpreting the vast amounts of data generated. Academic institutions, biotech startups, research organizations, and pharmaceutical corporations all contribute to the HTS market, with open innovation models facilitating collaboration and knowledge sharing. Drug repurposing, the process of discovering new uses for existing drugs, is also a significant application of HTS. The market for HTS is expected to grow significantly due to the increasing demand for new and effective treatments for various diseases.
Market Research Overview
High Throughput Screening (HTS) is a critical technology in the life sciences sector, enabling the rapid identification of potential drug candidates for complex illnesses such as cancer and neurological disorders. HTS utilizes compound libraries, automation, and specialized equipment like robotic arms, microplate readers, and high-resolution imaging systems to screen large numbers of compounds against specific targets. Data analytics plays a crucial role in HTS, with machine learning and data management systems used to organize, store, retrieve, integrate, and analyze genomic data and chemical databases. Collaborative networks and HTS service providers facilitate open innovation models and knowledge sharing among academic institutions, biotech startups, pharmaceutical corporations, and research organizations. Drug repurposing initiatives and biopharmaceutical industry leaders are leveraging HTS for precision medicine and target identification, while toxicology and stem cell research also benefit from this technology. The global healthcare sector continues to invest in HTS for drug discovery, clinical trials, and product development, driving the market for instruments, software, and consumables.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
ApplicationTarget Identification And ValidationPrimary And Secondary ScreeningToxicology AssessmentStem Cell ResearchEnd-userPharmaceutical And Biotechnology CompaniesAcademic And Research InstitutesCROsGeographyNorth AmericaEuropeAsiaRest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/high-throughput-screening-hts-market-to-grow-by-usd-19-9-billion-2024-2028-boosted-by-rising-rd-investments-with-ai-redefining-market-landscape—technavio-302364447.html
SOURCE Technavio
You may like
Technology
Portland Public Library Delivers Almost 50% Increase In User Engagement with New Web Redesign
Published
6 minutes agoon
April 21, 2026By
MIAMI, April 21, 2026 /PRNewswire/ — Digital Silk, an award-winning agency focused on creating brand strategies, custom websites, and digital marketing campaigns, announces the launch of a redesigned website for Portland Public Library, a public institution serving the education, community services, and nonprofit sector. The project focuses on improving user experience, content discoverability, and engagement while introducing a scalable CMS to support ongoing updates. The new platform is now live at https://www.portlandlibrary.org/.
The redesigned website reflects a strategic effort to better serve a diverse audience by improving navigation, enhancing accessibility, and creating clearer pathways to programs, events, and resources.
Improving Engagement Through User-Centric Design
Portland Public Library required a modern digital platform to address challenges related to fragmented navigation, limited engagement pathways, and difficulty in accessing content. The previous website structure made it harder for users to find relevant information efficiently.
Digital Silk addressed these challenges through a full website redesign supported by user-centric information architecture and optimized user journeys. The updated experience prioritizes clarity, accessibility, and ease of navigation across a wide range of services and resources.
“Organizations like public libraries are increasingly relying on their digital platforms to serve as primary engagement hubs, making usability and content clarity more important than ever,” said Ana Margarida Meira, VP, Client Partner.
Measurable Improvements in User Engagement
Following the launch, Portland Public Library recorded measurable improvements in engagement metrics when comparing Feb 17 to Mar 23, 2026, against the previous period.
Key outcomes include:
+47.82% increase in average engagement time per active user+4.5% increase in engaged sessions per active user+18.38% increase in average engagement time per session
These improvements may indicate stronger interaction with site content and increased user engagement across programs and services.
Key Deliverables Supporting Accessibility and Scalability
The project combined design, UX strategy, and technical development to support both immediate engagement improvements and long-term flexibility.
Core deliverables included:
Full website redesign and developmentUser-centric information architectureEngagement-focused UX design and user journey optimizationInclusive design enhancementsScalable CMS with modular content componentsPerformance optimization and QA testing
The implementation enables the library’s internal team to manage content more efficiently while supporting dynamic updates for seasonal programming and community initiatives.
Supporting a Shift Toward Inclusive Digital Experiences
The project reflects a broader trend among public institutions and content-heavy organizations to prioritize inclusive design, improved content discoverability, and scalable content management systems. Increasingly, organizations are focusing on engagement metrics as a measure of digital effectiveness.
“A well-structured, user-centric website can significantly increase engagement by making it easier for diverse audiences to find, explore, and interact with valuable resources and services,” said Ana Margarida Meira, VP, Client Partner.
Building a Foundation for Ongoing Community Engagement
The redesigned platform provides Portland Public Library with a flexible and scalable foundation to support future growth. By improving accessibility and navigation, the website is positioned to better connect users with educational programs, community services, and digital resources.
More information about Digital Silk’s web development capabilities is available at https://www.digitalsilk.com/ and organizations can request a quote here.
About Digital Silk
Digital Silk is an award-winning Miami Web Development Agency focused on growing brands online. With a team of seasoned experts, Digital Silk creates digital experiences through strategic branding, custom web design, and digital marketing services to help improve visibility and support engagement.
Media Contact
Jessica Erasmus
Marketing Director & PR Manager
Tel: (800) 206-9413
Email: jessica@digitalsilk.com
View original content:https://www.prnewswire.com/news-releases/portland-public-library-delivers-almost-50-increase-in-user-engagement-with-new-web-redesign-302747609.html
SOURCE Digital Silk
Technology
LUMA Vision to Showcase VERAFEYE 4D Imaging Platform at HRS 2026, Signaling a New Foundation for EP Guidance
Published
6 minutes agoon
April 21, 2026By
DUBLIN, April 21, 2026 /PRNewswire/ — LUMA Vision, a leader in real-time 4D cardiac imaging and navigation, today announced its participation in the Heart Rhythm Society Annual Meeting (HRS 2026) in Chicago, where the company will showcase its VERAFEYE™ Visualization and Guidance Platform and highlight new clinical progress through physician-led presentations and scientific sessions.
At HRS 2026, LUMA Vision will demonstrate how VERAFEYE enables direct, real-time visualization of cardiac anatomy, catheters, and therapy delivery—a step-change from conventional imaging and mapping approaches. By combining live 2D and 4D intra-procedural imaging with precise digital anatomical models, the platform delivers CT-quality visualization in seconds, supporting faster, more intuitive, and more precise procedures.
VERAEYE is redefining EP Guidance — from tools to platform, VERAFEYE is designed to eliminate the fragmentation of current EP workflows by enabling physicians to see and guide therapy in real time, rather than relying on the traditional three separate systems of point-by-point mapping, ICE and fluoroscopy. Early clinical experience demonstrates the platform’s ability to:
Enable efficient single-operator workflowsSupport multiple ablation technologiesEliminate the use of fluoroscopyIntroduce a true two-catheter procedure
LUMA Vision will be featured across multiple sessions:
Wednesday, April 22 | 3:00 PM Embassy Suites by Hilton Chicago
Dr. Shephal Doshi will present at the Stanford Biodesign New Arrhythmia Technologies Retreat, highlighting the role of real-time 4D imaging in advancing EP innovation.
Thursday, April 23 | 5:00 PM McCormick Place Convention Center • Room S406AB
Dr. Vivek Reddy will present “AF Ablation with a Large-Focal PFA Catheter & Integrated Guidance” at the 3rd Annual PFA LIVE Case Summit, featuring the VERAFEYE™ System in collaboration with CardioFocus.
Saturday, April 25 | Time 12:00 to 2:00 PM Abstract Pavilion, McCormick Place (Exhibit Hall)
Dr. Toni Breskovic will present new clinical data demonstrating real-world workflow validation and procedural impact.
“This is a defining moment not only for LUMA Vision, but for the future architecture of cardiac procedures. VERAFEYE is a globally unique, AI–powered system that sits at the intersection of electrophysiology, left atrial appendage closure, and structural heart interventions, designed as a unified operating layer rather than a standalone procedural tool,” said Fionn Lahart, CEO of LUMA Vision. “What we are introducing with VERAFEYE is a unified, real–time view of the heart that has the potential to become the foundation for how cardiac procedures are performed. As the field advances toward next–generation ablation technologies, guidance will no longer be an accessory. It will be the AI–enabled decision–making platform on which everything else is built.”
Driven by advanced AI algorithms, VERAFEYE interprets cardiac anatomy in real time, creating a single anatomical and guidance framework that spans multiple procedures. This intelligent foundation establishes a common procedural language through which therapies can enable greater precision, more efficient workflows, and tighter integration across the cardiac ecosystem.
Throughout the week, attendees are invited to visit Booth #2415 to meet the clinical team and experience how VERAFEYE delivers CT-quality digital anatomy in seconds, enabling a new level of precision and control in EP procedures. As EP continues to evolve toward energy-agnostic, platform-driven workflows, VERAFEYE is positioned to serve as a foundational imaging layer integrating across mapping systems.
About LUMA Vision
LUMA Vision is a privately held medical technology company headquartered in Dublin, Ireland, with key operations in Munich, Germany. The company designs and develops next-generation cardiac visualization and navigation systems that empower clinicians to see and treat with unmatched precision. VERAFEYE™, LUMA Vision’s flagship platform, delivers a real-time, 360° intracardiac view with an unprecedented field of visualization, redefining procedural accuracy in electrophysiology and structural heart interventions. Founded by CEO Fionn Lahart and CTO Christoph Hennersperger, LUMA Vision is committed to transforming cardiac care through innovation that improves outcomes and save lives.
Learn more at www.lumavision.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/luma-vision-to-showcase-verafeye-4d-imaging-platform-at-hrs-2026-signaling-a-new-foundation-for-ep-guidance-302747954.html
SOURCE LUMA Vision
Technology
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
Published
6 minutes agoon
April 21, 2026By
Technology Alliance Targets Indonesia’s Growing AI Inference Market, with an Initial Focus on Physical AI, Public Safety, Surveillance, and Industrial AI Applications
EL DORADO HILLS, Calif. and JAKARTA, Indonesia, April 21, 2026 /PRNewswire/ — Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (“Blaize,” the “Company,” “we,” “our,” or “us”), a global leader in programmable, energy efficient AI computing, and PT Datacomm Diangraha (“Datacomm”), one of Indonesia’s leading IT service providers and cloud infrastructure specialists, today announced the signing of a Memorandum of Understanding (MOU) establishing a technology alliance to explore the potential of AI inference solutions across Indonesia.
The MOU was signed during a ceremony at Gitex Asia 2026 in Singapore, marking a meaningful step in both companies’ shared commitment to advancing practical AI capabilities across the Indonesian market.
Indonesia: A Strategic AI Market
Indonesia is one of the fastest-growing AI markets in Asia Pacific, with global hyperscalers, sovereign infrastructure programs, and enterprise technology providers all accelerating their presence in the country. According to the Empowering Indonesia Report 2025 by Indosat Ooredoo Hutchison and research firm Twimbit, sovereign AI could contribute up to USD $140 billion to Indonesia’s GDP by 2030, driving annual economic growth of up to 6.8%. Indonesia’s AI sector is expanding at a 31% CAGR, the fastest rate in Southeast Asia (Marketing-Interactive, 2026). Blaize and Datacomm are positioning this technology alliance to serve that growing demand, with an initial focus on physical AI, public safety, surveillance, industrial AI, and logistics.
Areas of Exploration
Under the MOU, Blaize and Datacomm intend to explore the following areas of cooperation:
AI Inference as a Service on DCloud: Exploring integration of Blaize’s Hybrid AI platform with Datacomm’s DCloud public cloud platform and datacenter infrastructure to enable scalable inference services for enterprise customers across Indonesia.Physical AI, Public Safety, Surveillance, and Logistics: Exploring AI inference use cases spanning physical security, video analytics, smart surveillance, and logistics optimization across Indonesia’s enterprise and public sector.Industrial AI: Jointly exploring AI inference applications for industrial automation, including computer vision and sensor-driven intelligence for Indonesia’s industrial sector.
“Asia Pacific is at an inflection point for AI inference, and Indonesia stands out as one of the region’s most significant contributors to that growth,” said Dinakar Munagala, Co-Founder and Chief Executive Officer of Blaize. “Datacomm brings exactly the trusted, deeply embedded infrastructure presence and enterprise relationships this market requires. Together, we are exploring how Blaize’s programmable, energy-efficient AI platform can unlock real-world value across public safety, smart infrastructure, physical AI, and logistics throughout Indonesia. This alliance is a strong foundation, and we intend to build on it.”
“At Datacomm, we have spent over three decades earning the trust of Indonesia’s enterprises, government institutions, and critical infrastructure operators,” said Tan Wie Tjin, President Director and Founder of PT Datacomm Diangraha. “Indonesia is on the cusp of a significant AI transformation, and the demand for intelligent, scalable, and secure inference solutions is accelerating across every sector we serve. This alliance with Blaize is a natural and exciting step in our journey toward the AI era. The combination of Datacomm’s cloud and datacenter infrastructure with Blaize’s world-class AI inference platform positions us uniquely to serve this demand. I look forward to exploring the possibilities this technology alliance will unlock for our customers and for Indonesia’s digital future.”
The MOU is non-binding and outlines a cooperative technology framework under which the parties may pursue specific projects through future definitive agreements. The alliance will prioritize enabling secure, scalable, and energy-efficient AI inference solutions that integrate seamlessly into existing cloud, datacenter, and physical environments across Indonesia.
About Blaize
Blaize delivers a programmable AI platform, purpose-built for AI inference workloads in real-world environments. Its Hybrid AI architecture combines the Blaize GSP (Graph Streaming Processor), an efficient AI processor, with GPU-based infrastructure, enabling AI inference workloads to run across edge, cloud, and data center. Blaize solutions support computer vision, multimodal AI, and sensor-driven applications across smart cities, industrial automation, telecommunications, retail, logistics, and defense. Blaize is headquartered in El Dorado Hills, California, with a global presence across North America, Europe, the Middle East, and Asia. To learn more, visit www.blaize.com or follow us on LinkedIn @blaizeinc.
About Datacomm
PT Datacomm Diangraha is one of Indonesia’s leading IT service providers, with over 30 years of experience in building and managing critical digital infrastructure. Founded in 1990 and headquartered in South Jakarta, Datacomm has grown from a data communication reseller into a comprehensive technology services company with more than 450 employees. The company serves customers across the enterprise, telecommunications, government, and military sectors through an end-to-end IT ecosystem that supports business transformation, covering cloud services, modern data center solutions, advanced IT security, DevOps, and reliable network infrastructure.
For more information, visit www.datacomm.co.id
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are based on beliefs and assumptions and on information currently available to Blaize, including statements regarding the expected scope of the engagement with Datacomm and any potential definitive agreements related thereto; the industry in which Blaize operates, market opportunities, and product offerings. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) failure to realize the anticipated benefits of Blaize’s business combination with BurTech Acquisition Corp., which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; and (iii) those factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on March 24, 2026, our and other documents filed by Blaize from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Blaize assumes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law, including the securities laws of the United States and the rules and regulations of the SEC. Blaize does not give any assurance that it will achieve its expectations.
Blaize Contact
press@blaize.com
www.blaize.com
Investors
ir@blaize.com
www.blaize.com
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/blaize-and-datacomm-sign-technology-alliance-mou-to-explore-ai-inference-solutions-across-indonesia-302748491.html
SOURCE Blaize Inc.
Portland Public Library Delivers Almost 50% Increase In User Engagement with New Web Redesign
LUMA Vision to Showcase VERAFEYE 4D Imaging Platform at HRS 2026, Signaling a New Foundation for EP Guidance
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Send Rakhi to UK swiftly with UK Gifts Portal
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoInterfaith America Works to Promote Free, Fair and Peaceful Elections
-
Coin Market4 days agoFrench finance minister backs euro-pegged stablecoins to compete with US
-
Technology2 days agoHarmonic Enables DIRECTV to Reimagine Nationwide DTH Service
-
Near Videos4 days agoWe Have Only Scratched The Surface Of The Agentic Future
-
Coin Market4 days agoSingapore Gulf Bank adds stablecoin mint and redeem for 24/7 settlement
-
Near Videos4 days agoAnthropic Cuts Off OpenClaw Subscribers | GPT-Image-2 Leaked | Drift $285M Hack Explained
-
Technology4 days agoDynamite Integrates Biometric Cryptography and AI into its Wallet Product
-
Coin Market3 days agoBitcoin mining difficulty falls, but projected to rise in next adjustment
